The effect of growth factors, cytokines, and extracellular matrix proteins on fibronectin production in human vascular smooth muscle cells

Journal of Vascular Surgery

Volumn 31, Issue 3, 2000, Pages 577-584

  Kaiura, Terry L ^a   Itoh, Hiroyuki ^a   Kubaska III, Stephen M ^b   McCaffrey, Timothy A ^a   Liu, Bo ^a   Kent, K Craig ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; COLLAGEN TYPE 1; CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR BB; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR;

ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL INJURY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; VASCULAR SMOOTH MUSCLE;

EID: 0034064658     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2000.103692     Document Type: Article

References (40)

1. Topol EJ, Leya F, Pinkerton CA, et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993;329:221-7.
2. Donaldson MC, Mannick JA, Whittemore AD. Causes of primary graft failure after in situ saphenous vein bypass grafting. J Vasc Surg 1992;15:113-20.
3. Davies MG, Hagen PO. Pathobiology of intimai hyperplasia. Br J Surg 1994;81:1254-69.
4. Snow AD, Bolender RP, Wight TN, et al. Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am L Pathol 1990;137:313-8.
5. Kraiss LW, Kirkman TR, Kohler TR, et al. Shear stress regulates smooth muscle proliferation and neointimal thickening in porous polytetrafluoroethylene grafts. Arterioscler Thromb 1991;11:1844-50.
6. Nelson PR, Yamamura S, Kent KC. Extracellular matrix proteins are potent agonists of human smooth muscle cell migration. J Vasc Surg 1996;24:25-33.
7. Itoh H, Mureebe L, Kubaska S, et al. Type I collagen enhances phosphorylation of the PDGF receptor and acts synergistically to augment PDGF-induced vascular smooth muscle cell proliferation. Surgical Forum 1997;48:406-8.
8. Majesky MW, Lindner V, Twardzik DR, et al. Production of transforming growth factor β1 during repair of arterial injury. J Clin Invest 1991;88:904-10.
9. Hynes RO. Methods for identification of fibronectins, biosynthesis and fibrillogenesis. In: Rich A, editor. Fibronectins. New York: Springer-Verlag, Inc; 1990.
10. Carey DJ. Control of growth and differentiation of vascular cells by extracellular matrix proteins. Annu Rev Physiol 1991;53:161-77.
11. Boudreau N, Clausell N, Rabinovitch M, et al. Transforming growth factor-beta regulates increased ductus arteriosus endothelial glycosaminoglycan and a post-translational mechanism controls increased smooth muscle fibronectin features associated with intimal proliferation. Lab Invest 1992; 67:350-9.
12. Clausell N, de Lima VC, Molossi S, et al. Expression of tumour necrosis factor alpha and accumulation of fibronectin in coronary artery restenotic lesions retrieved by atherectomy. Br Heart J 1995;73:534-9.
13. Ferns GAA, Raines EW, Strugel KH, et al. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 991;253:1129-32.
14. Ross R, Glomset JA, Kariya B, et al. A platelet-dependent serum factor that stimulates the proliferation of smooth muscle cells in vitro. Proc Natl Acad Sci USA 1974;71:1207-10.
15. Thyberg J. Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cytol 1996; 16:183-231.
16. McCaffrey TA, Du B, Consigli S, et al. Genomic instability in the type II TGF-β1 receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest 1997;100:1-7.
17. Clark RA, McCoy GA, Folkvord JM, et al. TGF-β stimulates cultured human fibroblasts to proliferate and produce tissue-like fibroplasia: a fibronectin matrix-dependent event. J Cell Physiol 1997;170:60-80.
18. Tiggelman AMBC, Linthorst C, Boers W, et al. Transforming growth factor-β-induced collagen synthesis by human liver myofibroblasts is inhibited by α2-macroglobulin. J Hepatol 1997;26:1220-8.
19. Hansch GM, Wagner C, Burger A, et al. Matrix protein synthesis by glomerular mesangial cells in culture: effects of transforming growth factor-β and platelet-derived growth factor on fibronectin and collagen type IV mRNA. J Cell Physiol 1995;163:451-7.
20. Nikol S, Isner JM, Pickering JG, et al. Expression of transforming growth factor-β1 is increased in human vascular restenosic lesions. J Clin Invest 1992,90:1582-92.
21. Kanzaki T, Tamura K, Takahashi K, et al. In vivo effect of TGF-β1. Arterioscler Thromb Vasc Biol 1995;15:1951-7.
22. Mii S, Ware JA, Kent KC. Transforming growth factor-β inhibits human vascular smooth muscle cell growth and migration. Surgery 1993;114:464-70.
23. Miyagawa J, Higashiyama S, Kawata S, et al. Localization of heparin-binding EGF-like factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J Clin Invest 1995;95:404-11.
24. Rossi MJ, Chegini N, Masterson BJ. Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro. Endocrinology 1992;130:1716-27.
25. Seebacher T, Manske M, Kornblihtt AR, et al. Cellular fibronectin is induced by epidermal growth factor, but not by dexamethasone or cyclic AMP in rat liver epithelial cells. FEBS Lett 1988;239:113-6.
26. Chen LB, Gudor RC, Sun TT, et al. Control of a cell surface major glycoprotein by epidermal growth factor. Science 1977;197:776-8.
27. Deie M, Marui T, Allen CR, et al. The effects of age on rabbit MCL fibroblast matrix synthesis in response to TGF-β 1 or EGF. Mech Ageing Dev 1997;97:121-30.
28. Nikkari ST, Wight TN, Clowes AW. Smooth muscle cell expression of extracellular matrix genes after arterial injury [abstract]. FASEB J 1993;7:A791.
29. Aycock RS, Raghow R, Stricklin GP, et al. Post-transcriptional inhibition of collagen and fibronectin synthesis by a synthetic homolog of a portion of the carboxyl-terminal propeptide of human type I collagen. J Biol Chem 1986; 261:14355-60.
30. Hedin U, Bottger BA, Forsberg E, et al. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol 1988;107: 307-19.
31. Holderbaum D, Ehrhart LA. Substratum influence on collagen and fibronectin biosynthesis by arterial smooth muscle cells in vitro. J Cell Physiol 1986;126:216-24.
32. Sharifi BG, LaFleur DW, Pirola CJ, et al. Angiotensin II regulates tenascin gene expression in vascular smooth muscle cells. J Biol Chem 1992;267:23910-5.
33. O'Donohoe MK, Schwartz LB, Radic ZS, et al. Chronic ACE inhibition reduces intimai hyperplasia in experimental vein grafts. Ann Surg 1991;214:727-32.
34. Powell JS, Clozel JP, Muller RKM, et al. Inhibitors of angiotensin converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-8.
35. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest 1987;79:1-6.
36. Blatti SP, Foster DN, Ranganathan G, et al. Induction of fibronectin gene transcription and mRNA is a primary response to growth-factor stimulation of AKR-2B cells. Proc Natl Acad Sci 1988;85:1119-23.
37. Albrecht DE, Tidball JG. Platelet-derived growth factor-stimulated secretion of basement membrane proteins by skeletal muscle occurs by tyrosine kinase-dependent and independent pathways. J Biol Chem 1997;272:2236-44.
38. Rutherford C, Martin W, Salame M, et al. Substantial inhibition of new-intimal response to balloon injury in the rat carotid artery using a combination of antibodies to platelet-derived growth factor-BB and basic fibroblast growth factor. Atherosclerosis 1997;130:45-51.
39. Bujia J. Effect on growth factors on cell proliferation and matrix synthesis in cultured human chondrocytes. Laryngorhinootologie 1995;74:444-9.
40. Rakugi H, Jacob HJ, Krieger JE, et al. Vascular injury induces angiotensinogen gene expression in the media and neointima. Circulation 1993;87:283-90.